Brochure
3 Nov 2022
Elevator Pitch
PPTX
HFM is
a Californian-Swiss
Biotech
company developing new drugs
in virology, immunology
and
oncology
with
a focus
on COVID-19
since December 2019.
Acute and even more Chronic Covid continue to remain major challenges.
There are a few drugs on the market which are however not being used widely due to lack of efficacy
and difficult challenges in prescriptions. Also
vaccines are not the solution for various reasons.
We have developed two drugs against
acute and chronic Covid- 19, preventive as well as for
treatment, ready for market entry in
Q4 -2022.
Content provided by our supplier
Hybrid Fusion Medicals - HFM AG
-
Country/Region:Switzerland
-
On CPHI since:2022
-
Employees:1 - 24
Company types
Primary activities